This week, five medical devices stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).
This week, Winner Medical Group (WWIN) is making solid headway. The company’s rating improves to an A (“strong buy”) from last week’s B (“buy”) rating. Winner Medical Group engages in the research, development, manufacture, and marketing of cotton-base medical dressings and medical disposables. For more information, get Portfolio Grader’s complete analysis of WWIN stock.
Hill-Rom Holdings, Inc. (HRC) is bettering its rating of C (“hold”) from last week to a B (“buy”) this week. Hill-Rom Holdings manufactures equipment for the healthcare industry, and provides wound care and pulmonary/trauma management services. For more information, get Portfolio Grader’s complete analysis of HRC stock.
CryoLife, Inc.’s (CRY) ratings are looking better this week, moving up to a B from last week’s C. CryoLife preserves and distributes human tissues in addition to developing, manufacturing, and commercializing medical devices for cardiac and vascular transplant applications. For more information, get Portfolio Grader’s complete analysis of CRY stock.
The rating of Natus Medical Incorporated (BABY) moves up this week, rising from a B to an A. Natus Medical is a medical device company that develops, manufactures, and markets screening products. For more information, get Portfolio Grader’s complete analysis of BABY stock.
ResMed Inc. (RMD) is seeing ratings go up from a B last week to an A this week. ResMed develops, manufactures and distributes medical equipment for treating, diagnosing and managing sleep-disordered breathing and other respiratory disorders. For more information, get Portfolio Grader’s complete analysis of RMD stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.